Freeze dry preparation containing diclofenac salt and lidocaine and its preparation method

A technology of diclofenac salt and lidocaine, which is applied to the freeze-dried preparation containing diclofenac salt and lidocaine and the field of preparation thereof, can solve problems such as cost increase, and achieve the effects of reduced production energy consumption, low energy consumption and convenient transportation

Inactive Publication Date: 2005-11-02
BEIJING SIHUAN KEBAO PHARM CO LTD
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Commercially available injections use light-proof packaging materials, which increases the cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Take 100g of Tween-80, add it to about 1200ml of water for injection at about 40°C, stir to dissolve, add 75g of diclofenac sodium and stir to dissolve. Dissolve 23.1 g of lidocaine hydrochloride with a small amount of water for injection and add to the above solution under constant stirring, and adjust the pH value to about 8.0 with 5 mol / L sodium hydroxide solution. Then add 240g of mannitol, 2g of sodium bisulfite, and 0.2g of disodium edetate and stir to dissolve completely; add water for injection to 2000ml. Add 0.05% (g / ml) activated charcoal for needles to the liquid medicine, stir at room temperature for 30 minutes, decarbonize and filter. Measure the pH value and main drug content. Sterilize by fine filtration with a 0.22 μm microporous membrane filter. Under aseptic conditions, the resulting solution was placed in sterile vials (2ml each), freeze-dried according to conventional methods, and sealed. The lyophilized powder preparation A containing diclofenac ...

Embodiment 2

[0030]Take 100g of Tween-80, add about 2000ml of water for injection, stir to dissolve, add 75g of diclofenac sodium and stir to dissolve. Dissolve 23.1 g of lidocaine hydrochloride with a small amount of water for injection and add it into the above solution under constant stirring, and adjust the pH value to about 8.5 with 5 mol / L sodium trisodium phosphate solution. Then add 240g mannitol and 2g sodium bisulfite and stir to dissolve completely; add water for injection to 5000ml. Add 0.05% (g / ml) activated charcoal for needles to the liquid medicine, stir for 30 minutes, decarbonize and filter. Measure the pH value and main drug content. Sterilize by fine filtration with a 0.22 μm microporous membrane filter. Under aseptic conditions, the resulting solution was placed in sterile vials (5ml each), freeze-dried according to conventional methods, and sealed. The freeze-dried powder preparation B containing diclofenac and lidocaine of the present invention is obtained.

Embodiment 3

[0032] Take 200g of Tween-80, 240g of mannitol, and 2g of sodium bisulfite, add them to about 1500ml of water for injection, stir to dissolve, add 75g of diclofenac sodium and stir to dissolve. Dissolve 23.1g of lidocaine hydrochloride with a small amount of water for injection and add to the above solution under constant stirring, adjust the pH value to about 7.5 with phosphate buffer solution; add water for injection to 2000ml. Add 0.05% (g / ml) activated charcoal for needles to the liquid medicine, stir for 30 minutes, decarbonize and filter. Measure the pH value and main drug content. Sterilize by fine filtration with a 0.22 μm microporous membrane filter. Under aseptic conditions, the resulting solution was placed in sterile vials (2ml each), freeze-dried according to conventional methods, and sealed. The lyophilized powder preparation C containing diclofenac and lidocaine of the present invention is obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The freeze dried powder for injection containing diclofenac salt and lidocaine is prepared with Tween-80, pharmaceutically acceptable solution pH regulator, solution of diclofenac salt and lidocaine of pH 7.0 and in effective treating amount, and through freeze drying. The solution may contain other pharmaceutically acceptable supplementary material. The preparation of the present invention has stable performance, easy transportation, long storage period, and no bad reaction caused by alcohol and other organic solvent.

Description

[0001] The technical field [0002] The invention belongs to the field of pharmaceutical preparations, and specifically relates to a freeze-dried preparation containing diclofenac and lidocaine for pain caused by osteoarthritis, rheumatoid arthritis and other various non-rheumatic inflammations and a preparation method thereof. technical background [0003] Diclofenac is a representative anti-inflammatory and analgesic drug among phenylacetic acids. It mainly inhibits cyclooxygenase and prevents arachidonic acid from being converted into prostaglandins. It has two isomers COX-1 and COX of cyclooxygenase. -2 has a similar effect. Compared with many traditional non-steroidal anti-inflammatory drugs (the effect of inhibiting COX-1 is significantly higher than that of COX-2), it has relatively mild gastrointestinal reactions at equivalent anti-inflammatory doses. Diclofenac sodium or diclofenac potassium is one of the most commonly used non-steroidal anti-inflammatory drugs with s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/196
Inventor 孟凡清
Owner BEIJING SIHUAN KEBAO PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap